Polish RNA Biology Meeting
September 28-30, 2023
Warsaw
Eclipsebio’s Posters
Scientists from Eclipsebio regularly present posters at conferences world-wide. Our studies involve the development of RNA genomics technologies and how they can accelerate tomorrow’s key RNA discoveries & medicines.
See Posters
eCLIP Validated Antibodies from Cell Signaling Technology
- Eclipsebio has partnered with antibody provider, Cell Signaling Technology (CST), to present data demonstrating the importance of antibody validation and how using pre-validated eCLIP antibodies can expedite a successful eCLIP experiment
Enabling RNA Therapeutics and Manufacturing Quality Control
- Read about the RNA genomics assays developed at Eclipsebio to enable and accelerate RNA drug development through detailed end-to-end analysis and characterization of RNA
Deep quantitative profiling of miRNA and siRNA targets using miR-eCLIP enrichment of sRNA:target chimeras
- Building on the miR-eCLIP proof of concept to study direct targets of miRNAs, we are now exploring how this technology can be utilized to identify off-target interactions of siRNAs
- miR-eCLP provides a snapshot of miRNA-target and siRNA off-target interactions that can both be useful for researchers studying the biology of these RNAs as well as for robust development of RNAi-based therapeutics
eCLIP Validated Antibodies from Cell Signaling Technology
- Eclipsebio has partnered with antibody provider, Cell Signaling Technology (CST), to present data demonstrating the importance of antibody validation and how using pre-validated eCLIP antibodies can expedite a successful eCLIP experiment
Enabling RNA Therapeutics and Manufacturing Quality Control
- Read about the RNA genomics assays developed at Eclipsebio to enable and accelerate RNA drug development through detailed end-to-end analysis and characterization of RNA
Deep quantitative profiling of miRNA and siRNA targets using miR-eCLIP enrichment of sRNA:target chimeras
- Building on the miR-eCLIP proof of concept to study direct targets of miRNAs, we are now exploring how this technology can be utilized to identify off-target interactions of siRNAs
- miR-eCLP provides a snapshot of miRNA-target and siRNA off-target interactions that can both be useful for researchers studying the biology of these RNAs as well as for robust development of RNAi-based therapeutics